Market Overview:
The global L-glutamine (Gln) market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for L-glutamine in the pharmaceutical and nutraceutical industries. Pharmaceutical grade is the most commonly used type of L-glutamine, followed by nutraceutical grade and other types. Nutraceutical use accounts for the majority of the global demand for L-glutamine, followed by pharmaceutical use and other applications. North America dominates the global market for L-glutamine, followed by Europe, Asia Pacific, Latin America and Middle East & Africa.
 Industry Outlook.svg)
Product Definition:
L-Glutamine is a nonessential amino acid that is synthesized in the body from glutamate and ammonia. It plays a role in protein synthesis, cell proliferation and healing. L-glutamine can also be taken as a supplement to help improve athletic performance, muscle growth and weight loss.
Pharmaceutical Grade:
Pharmaceutical grade is a term used for products that are of the highest quality and purity. It's majorly used in drug manufacturing, however it can be applied to any process where high-quality materials are required. Pharmaceutical grade L-glutamine (Gln) is intended for human consumption and has been characterized as safe for use within the pharmaceutical industry.
Nutraceutical Grade:
Nutraceutical grade is the highest quality form of a dietary supplement and it's used in L-glutamine (Gln) market. Nutraceuticals are nutraceutical products that are consumed for their health benefits rather than as a medication. They comprise various vitamins, minerals, herbs & other ingredients that help in improving body functions & performance along with supporting overall health.
The product has become increasingly popular among sportsmen.
Application Insights:
Nutraceutical use of glutamine accounted for the largest revenue share in 2017. The product is widely used as a nutritional supplement to promote lean muscle growth and improve sports performance. It also helps in reducing stress, boosting metabolism, healing wounds faster, controlling blood sugar levels and improving digestion. Pharmaceutical use of glutamine is projected to witness the fastest growth over the forecast period owing to its wide-spread applications in pharmaceutical formulations such as tablets & capsules.
The other application segment includes formulation of cosmetics & toiletries products including shampoos, shower gels & soaps where it is used as an emulsifier or pH regulator among others. Increasing demand for these formulations from various industries including cosmetics and personal care are expected to drive market growth over the forecast period (18 ¢â€š¹ 28).
Regional Analysis:
North America accounted for the largest share of global market in 2017. The region is expected to maintain its dominance over the forecast period owing to high prevalence of obesity and diabetes, which are majorly caused due to a lack of proper nutrition. In addition, rising awareness about health benefits associated with L-glutamine is also one factor responsible for maintaining its largest market share in North America.
Asia Pacific is anticipated to be the fastest growing regional segment during the forecast period owing to increasing demand from nutraceutical industry as well as pharmaceutical industry coupled with rising disposable income levels in emerging economies such as China and India. Moreover, increasing R&D activities related with nutritional products are also driving growth across this region.
Growth Factors:
- Increasing demand for Gln in the nutraceuticals and dietary supplements industry as a result of its purported health benefits.
- Growing popularity of Gln as a sports supplement, especially among athletes and bodybuilders.
- Increased research on the therapeutic potential of Gln for various medical conditions such as cancer, diabetes, and liver disease.
- Rising demand from the food processing industry for use in meat products, bakery items, and other processed foods.
- Growing awareness about the benefits of glutamine supplementation among consumers
Scope Of The Report
Report Attributes
Report Details
Report Title
L-Glutamine (Gln) Market Research Report
By Type
Pharmaceutical Grade, Nutraceutical Grade, Other
By Application
Nutraceutical Use, Pharmaceutical Use, Others
By Companies
Ajinomoto, Kyowa Hakko Kirin, Daesang, Meihua, Fufeng
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global L-Glutamine (Gln) Market Report Segments:
The global L-Glutamine (Gln) market is segmented on the basis of:
Types
Pharmaceutical Grade, Nutraceutical Grade, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Nutraceutical Use, Pharmaceutical Use, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ajinomoto
- Kyowa Hakko Kirin
- Daesang
- Meihua
- Fufeng
 Market Overview.svg)
Highlights of The L-Glutamine (Gln) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmaceutical Grade
- Nutraceutical Grade
- Other
- By Application:
- Nutraceutical Use
- Pharmaceutical Use
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the L-Glutamine (Gln) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
L-Glutamine is an amino acid that is found in the body and helps to provide energy for the muscles. It can also help to improve mood and cognitive function.
Some of the key players operating in the l-glutamine (gln) market are Ajinomoto, Kyowa Hakko Kirin, Daesang, Meihua, Fufeng.
The l-glutamine (gln) market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. L-Glutamine (Gln) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. L-Glutamine (Gln) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. L-Glutamine (Gln) Market - Supply Chain
4.5. Global L-Glutamine (Gln) Market Forecast
4.5.1. L-Glutamine (Gln) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. L-Glutamine (Gln) Market Size (000 Units) and Y-o-Y Growth
4.5.3. L-Glutamine (Gln) Market Absolute $ Opportunity
5. Global L-Glutamine (Gln) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. L-Glutamine (Gln) Market Size and Volume Forecast by Type
5.3.1. Pharmaceutical Grade
5.3.2. Nutraceutical Grade
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global L-Glutamine (Gln) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. L-Glutamine (Gln) Market Size and Volume Forecast by Application
6.3.1. Nutraceutical Use
6.3.2. Pharmaceutical Use
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global L-Glutamine (Gln) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. L-Glutamine (Gln) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global L-Glutamine (Gln) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. L-Glutamine (Gln) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global L-Glutamine (Gln) Demand Share Forecast, 2019-2026
9. North America L-Glutamine (Gln) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America L-Glutamine (Gln) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America L-Glutamine (Gln) Market Size and Volume Forecast by Application
9.4.1. Nutraceutical Use
9.4.2. Pharmaceutical Use
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America L-Glutamine (Gln) Market Size and Volume Forecast by Type
9.7.1. Pharmaceutical Grade
9.7.2. Nutraceutical Grade
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America L-Glutamine (Gln) Demand Share Forecast, 2019-2026
10. Latin America L-Glutamine (Gln) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America L-Glutamine (Gln) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America L-Glutamine (Gln) Market Size and Volume Forecast by Application
10.4.1. Nutraceutical Use
10.4.2. Pharmaceutical Use
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America L-Glutamine (Gln) Market Size and Volume Forecast by Type
10.7.1. Pharmaceutical Grade
10.7.2. Nutraceutical Grade
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America L-Glutamine (Gln) Demand Share Forecast, 2019-2026
11. Europe L-Glutamine (Gln) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe L-Glutamine (Gln) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe L-Glutamine (Gln) Market Size and Volume Forecast by Application
11.4.1. Nutraceutical Use
11.4.2. Pharmaceutical Use
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe L-Glutamine (Gln) Market Size and Volume Forecast by Type
11.7.1. Pharmaceutical Grade
11.7.2. Nutraceutical Grade
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Prjections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe L-Glutamine (Gln) Demand Share, 2019-2026
12. Asia Pacific L-Glutamine (Gln) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific L-Glutamine (Gln) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific L-Glutamine (Gln) Market Size and Volume Forecast by Application
12.4.1. Nutraceutical Use
12.4.2. Pharmaceutical Use
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific L-Glutamine (Gln) Market Size and Volume Forecast by Type
12.7.1. Pharmaceutical Grade
12.7.2. Nutraceutical Grade
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific L-Glutamine (Gln) Demand Share, 2019-2026
13. Middle East & Africa L-Glutamine (Gln) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa L-Glutamine (Gln) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa L-Glutamine (Gln) Market Size and Volume Forecast by Application
13.4.1. Nutraceutical Use
13.4.2. Pharmaceutical Use
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa L-Glutamine (Gln) Market Size and Volume Forecast by Type
13.7.1. Pharmaceutical Grade
13.7.2. Nutraceutical Grade
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa L-Glutamine (Gln) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global L-Glutamine (Gln) Market: Market Share Analysis
14.2. L-Glutamine (Gln) Distributors and Customers
14.3. L-Glutamine (Gln) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Ajinomoto
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Kyowa Hakko Kirin
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Daesang
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Meihua
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Fufeng
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
